| Breakdown | TTM | Dec 2024 | Dec 2023 | Dec 2022 | Dec 2021 | Dec 2020 |
|---|---|---|---|---|---|---|
Income Statement | ||||||
| Total Revenue | 137.33M | 149.61M | 136.58M | 101.91M | 91.84M | 86.86M |
| Gross Profit | 85.40M | 96.15M | 94.70M | 95.17M | 88.41M | 78.63M |
| EBITDA | 19.00M | 32.10M | 34.30M | 39.91M | 37.26M | 28.13M |
| Net Income | 13.28M | 23.67M | 25.00M | 28.78M | 26.43M | 19.26M |
Balance Sheet | ||||||
| Total Assets | 2.70B | 2.78B | 2.71B | 2.65B | 2.42B | 2.28B |
| Cash, Cash Equivalents and Short-Term Investments | 361.26M | 468.77M | 620.84M | 688.46M | 819.01M | 663.15M |
| Total Debt | 52.66M | 118.52M | 40.80M | 105.76M | 25.54M | 11.11M |
| Total Liabilities | 2.45B | 2.56B | 2.52B | 2.48B | 2.21B | 2.08B |
| Stockholders Equity | 245.31M | 215.31M | 195.24M | 166.39M | 211.46M | 199.70M |
Cash Flow | ||||||
| Free Cash Flow | 32.39M | 26.19M | 30.42M | 34.62M | 35.09M | 27.79M |
| Operating Cash Flow | 35.40M | 29.82M | 30.88M | 35.05M | 35.46M | 28.66M |
| Investing Cash Flow | 96.65M | -57.72M | -82.38M | -252.62M | -242.48M | -495.85M |
| Financing Cash Flow | -104.84M | 38.10M | 32.48M | 246.46M | 125.47M | 453.82M |
Name | Overall Rating | Market Cap | P/E Ratio | ROE | Dividend Yield | Revenue Growth | EPS Growth |
|---|---|---|---|---|---|---|---|
82 Outperform | $287.18M | 9.78 | 11.48% | 2.91% | 8.17% | 21.95% | |
78 Outperform | $260.19M | 19.50 | 5.69% | 2.40% | -6.25% | -38.79% | |
72 Outperform | $250.76M | 9.44 | 11.95% | 3.61% | 17.97% | 68.34% | |
71 Outperform | $293.60M | 8.82 | 11.15% | 2.84% | 12.91% | 21.72% | |
68 Neutral | $361.25M | 19.77 | 8.27% | 2.13% | 7.29% | 33.75% | |
68 Neutral | $18.00B | 11.42 | 9.92% | 3.81% | 9.73% | 1.22% | |
67 Neutral | $330.73M | 38.24 | 2.25% | 3.06% | 9.90% | ― |
On November 18, 2025, Chemung Financial Corporation announced a quarterly cash dividend of $0.34 per share, to be paid on January 2, 2026, to shareholders of record as of December 19, 2025. This announcement reflects the company’s ongoing commitment to returning value to its shareholders and may positively influence its market positioning and stakeholder confidence.
The most recent analyst rating on (CHMG) stock is a Hold with a $54.00 price target. To see the full list of analyst forecasts on Chemung Financial stock, see the CHMG Stock Forecast page.
During the fourth quarter of 2025, Chemung Financial Corporation’s management plans to engage with institutional investors to discuss strategic initiatives and recent performance. The company has demonstrated robust financial health with a 6.3% increase in quarterly dividends and significant loan growth. The restructuring of its balance sheet, including the sale of low-yielding securities and the raising of subordinated debt, aims to enhance profitability and strengthen capital ratios. This strategic move is expected to improve the company’s earnings and market positioning, particularly in high-growth areas like Albany and Buffalo.
The most recent analyst rating on (CHMG) stock is a Hold with a $55.00 price target. To see the full list of analyst forecasts on Chemung Financial stock, see the CHMG Stock Forecast page.